Navigation Links
Company Appoints New SVP, Marketing for PBM Business
Date:11/4/2009

WOONSOCKET, R.I., Nov. 4 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced the appointment of Len Greer to the position of SVP, Marketing for its pharmacy benefit management business. Greer assumes responsibility for the company's PBM marketing from Jack Bruner, who is transitioning to the new role of EVP, Strategic Development.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )

Greer brings twenty years of experience in marketing, strategy and product development to CVS Caremark. He joins the company from ActiveHealth where he was the EVP, Marketing responsible for developing and implementing marketing strategies to drive brand awareness in the health plan and plan sponsor marketplace. Prior to his tenure with ActiveHealth he spent six years at Medco Health in various senior marketing roles. Before joining Medco, Greer was a management consultant at McKinsey & Company, where he assisted clients on issues of marketing, strategy, product development and operations.

"Len's analytical background, knowledge of the industry and strong marketing skills make him uniquely qualified to help deliver our messages effectively in the marketplace," commented Tom Ryan, President, Chairman and CEO.

Len holds a bachelor's degree from the Illinois Institute of Technology and a master's degree in business administration from the University of Michigan.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 7,000 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at www.cvscaremark.com/investors, as well as through the press room section of the Company's Web site, at www.cvscaremark.com/newsroom.

    Media Contact:
    Eileen Howard Dunn                  Nancy Christal
    CVS Caremark                        CVS Caremark
    Senior Vice President               Senior Vice President
    Corporate Communications            Investor Relations
    (401) 770-4561                      (914) 722-4704

SOURCE CVS Caremark


'/>"/>
SOURCE CVS Caremark
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
2. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
3. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
4. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
5. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
8. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
9. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
10. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
11. Maine Natural Health Company Conducts Dental Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... COTTAGE, N.Y. , May 22, 2017 /PRNewswire/ ... antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of a ... plain English, the results of a clinical study ... one year treatment with Gene-Eden-VIR/Novirin in individuals suffering ... important to note that there are no other ...
(Date:5/18/2017)... -- Two Bayer U.S. Pharmaceutical leaders received top awards from ... th Woman of the Year event ... mission of furthering the advancement and impact of women ... Powell-Steffen , senior director of brand activation and inside ... Howe , a regional business manager for New England ...
(Date:5/15/2017)... ATLANTA , May 15, 2017  Amy Baxter ... the industry leader in noninvasive pain relief, was awarded ... MM&M magazine. Baxter was recognized at the MM&M ... New York City on May 10, ... helping the biopharma industry go "beyond the pill."  ...
Breaking Medicine Technology:
(Date:5/26/2017)... , ... May 26, 2017 , ... After raising nearly ... Top gadget will continue to be available at a discounted crowdfunding price on ... stress wherever they are, I also wanted to bring a fidget toy to the ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Dr. Alex Rabinovich, ... to announce a new, informational blog post on insurance options. If a Bay Area ... plans may help save time and money. Visiting an in-network provider for a second ...
(Date:5/26/2017)... ... 2017 , ... “Just What Happened in the Garden of Eden”: retells the stories of three ... the creation of published author, Penelope Colt, mother, trader, horse farmer, artist and a former ... she was three. At six, they moved to Dayton, Ohio, where Penny graduated high ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... and choosing the most appropriate instruments for research and understanding the basic principles ... This webinar will focus on innovations in stereo microscopy for brightfield and fluorescence ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... dental implants in Bayside, NY, who have now spent 10 years as clinical ... New York University (NYU) College of Dentistry. Through the program, private practitioners receive ...
Breaking Medicine News(10 mins):